Peng, N.-X. (2015) “Combination of axitinib and dasatinib for anti-cancer activities in two prostate cancer cell lines”, Bangladesh Journal of Pharmacology, 11(1), pp. 130–137. doi: 10.3329/bjp.v11i1.24149.